MedTrace Logo

Human Psychopharmacology of Salvinorin A

NCT00996411 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2014-03-24

No results posted yet for this study

Summary

This study is characterizing the subject-rated and behavioral effects of salvinorin A in healthy volunteers. The investigators hypothesize the salvinorin A will have hallucinogen-like effects.

Conditions

  • Healthy

Interventions

DRUG

Salvinorin A

This is an initial dose ranging study

Sponsors & Collaborators

Principal Investigators

  • Roland Griffiths, Ph.D. · Johns Hopkins University

  • Matthew W Johnson, Ph.D. · Johns Hopkins University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00996411 on ClinicalTrials.gov